[{"indications": "Indications\u00a0prevention of severe recurrent migraine, cluster headache and other\r\nvascular headaches in patients who are refractory to other treatment\r\nand whose lives are seriously disrupted (important: hospital supervision only, see notes above); diarrhoea associated\r\nwith carcinoid syndrome", "name": "METHYSERGIDE ", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.7 Analgesics", "4.7.4 Antimigraine drugs", "4.7.4.2 Prophylaxis of migraine", "METHYSERGIDE"], "cautions": "Cautions\u00a0history of peptic ulceration; avoid abrupt withdrawal of treatment; after 6 months withdraw (gradually over 2 to 3 weeks) for reassessment\r\nfor at least 1 month (see also notes above); interactions: Appendix 1 (ergot alkaloids)", "side-effects": "Side-effects\u00a0nausea, vomiting, heartburn, abdominal discomfort,\r\ndrowsiness, and dizziness occur frequently in initial treatment; mental\r\nand behavioural disturbances, insomnia, oedema, weight gain, rashes,\r\nloss of scalp hair, cramps, arterial spasm (including coronary artery\r\nspasm with angina and possible myocardial infarction), paraesthesias\r\nof extremities, postural hypotension, and tachycardia also occur;\r\nretroperitoneal and other abnormal fibrotic reactions may occur on\r\nprolonged administration, requiring immediate withdrawal of treatment", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3571.htm", "doses": ["Initially 1\u00a0mg at bedtime, increased gradually over about\r\n2 weeks to 1\u20132\u00a0mg 3 times daily with food (see notes above); child not recommended", "Diarrhoea associated with carcinoid syndrome, usual range, 12\u201320\u00a0mg\r\ndaily (hospital supervision); child not recommended"], "pregnancy": "Pregnancy\u00a0avoid"}]